PROSPECT: PROficiency Based StePwise Endovascular Curricular Training: Multicentric Registry

Sponsor
University Ghent (Other)
Overall Status
Recruiting
CT.gov ID
NCT05620186
Collaborator
(none)
120
3
2
119.5
40
0.3

Study Details

Study Description

Brief Summary

The goal of this multicentric registry is to gather data from trainees completing PROSPECT: a PROficiency Based StePwise Endovascular Curricular Training to obtain basic cognitive and technical skills. The main goals are to identify if:

  • Results from a previous randomised controlled trail can be reproduced in real life.

  • Evaluate skills retention after program completion.

  • Assess real life implementation of the training program.

Condition or Disease Intervention/Treatment Phase
  • Other: PROSPECT
N/A

Detailed Description

A validated PROSPECT (PROficiency-based StePwise Endovascular Curricular Training) training has been integrated into the training of surgical residents to teach basic cognitive, technical and non-technical endovascular skills. The program uses virtual reality simulation and E-learning. During the four modules of the program, formative feedback is given after each training session. Only after achieving a predetermined benchmark score, trainees can progress to the next module.

Surgical trainees completing PROSPECT showed superior real live endovascular performance compared to the traditionally trained in a single centre randomised controlled trial (RCT). The curriculum was integrated locally, but also introduced in other centers: national and international. Local tutors teach the curriculum to trainees after standardized training on the modalities of PROSPECT by the researchers of the Ghent.

A registry is maintained and coordinated by the Ghent research group in which all educational data regarding this training is collected and processed anonymously.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Registry, no comparisonRegistry, no comparison
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Registry Endovascular Training Curriculum PROSPECT for Surgical Trainees (PROficiency-based StePwise Endovascular Curricular Training Program)
Actual Study Start Date :
Oct 17, 2017
Anticipated Primary Completion Date :
Oct 1, 2027
Anticipated Study Completion Date :
Oct 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Other: Original PROSPECT

Original, distributed PROSPECT where trainees learn at their own pace in between, before/after clinical activities

Other: PROSPECT
PROficiency Based StePwise Endovascular Curricular Training

Other: Massed PROSPECT

Massed, bootcamp-style training form of PROSPECT where trainees are exempt from clinical duties

Other: PROSPECT
PROficiency Based StePwise Endovascular Curricular Training

Outcome Measures

Primary Outcome Measures

  1. Cognitive skills [comparison before program start and after completion. This means through study completion.]

    Multiple Choice Question test (min: 0, max: 20, the higher the score, the better)

  2. Technical skills [comparison before program start and after completion. This means through study completion.]

    Rating scale assessment and simulator metrics

Secondary Outcome Measures

  1. Cognitive skills retention [3, 6 and 12 months after program completion]

    Multiple Choice Question test (min: 0, max: 20, the higher the score, the better)

  2. Technical skills retention [3, 6 and 12 months after program completion]

    Rating scale assessment and simulator metrics

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Surgical trainee

  • Knowledge and technical skill level evaluated

  • Demographics questionnaire and general MCQ test completed

  • Endovascular simulated exercise completed after familiarization with the simulator

Exclusion Criteria:
  • N/A

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Ghent Ghent Belgium 9000
2 KU Leuven Leuven Belgium 3000
3 CAMES Copenhagen Denmark 2100

Sponsors and Collaborators

  • University Ghent

Investigators

  • Principal Investigator: Isabelle Van Herzeele, MD, PhD, University Hospital, Ghent

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Ghent
ClinicalTrials.gov Identifier:
NCT05620186
Other Study ID Numbers:
  • B670201630090
First Posted:
Nov 17, 2022
Last Update Posted:
Nov 17, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by University Ghent
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 17, 2022